HARMONIC’s Fifth and Last Annual Meeting Shows Great Progress
The Harmonic consortium held its fifth and final annual meeting on 28-29 May in Leuven, Belgium, to discuss progress made by each Work Package (WP) and next steps […]
The Harmonic consortium held its fifth and final annual meeting on 28-29 May in Leuven, Belgium, to discuss progress made by each Work Package (WP) and next steps […]
These results will help to better predict the risk of developing secondary cancers after radiotherapy […]
The study shows that the doses absorbed by organs far from the treatment volume are substantially smaller in proton therapy than in external beam photon therapy, even when taking into account the imaging dose. For cancer patients receiving radiotherapy, reducing radiation exposure of normal tissue can prevent adverse effects, such [...]
In the latest issue of the International Journal of Molecular Sciences, HARMONIC researchers provide a detailed overview of the rationale, design and methods for understanding how radiotherapy affects our body and which biomarkers can be used to predict long-term health risks. Radiotherapy has saved the lives of countless young cancer [...]
Share HARMONIC newsletters and help maximise the impact of the project during and beyond its lifespan! […]
Marie Odile Bernier is a researcher at France's Institut de Radioprotection et de Sûreté Nucléaire (IRSN) and co-leader of Work Package 3 in Harmonic. Here, she tells us about her work and shares some advice. Marie Odile Bernier Can you briefly explain who you are and what you [...]
By Isabelle Thierry-Chef, ISGlobal researcher and principal investigator of the HARMONIC project. […]